SANDOZ INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SANDOZ INC, and what generic and branded alternatives to SANDOZ INC drugs are available?
SANDOZ INC has twenty-six approved drugs.
There are nineteen tentative approvals on SANDOZ INC drugs.
Summary for SANDOZ INC
US Patents: | 0 |
Tradenames: | 19 |
Ingredients: | 18 |
NDAs: | 26 |
Patent Litigation for SANDOZ INC: | See patent lawsuits for SANDOZ INC |
PTAB Cases with SANDOZ INC as petitioner: | See PTAB cases with SANDOZ INC as petitioner |
Drugs and US Patents for SANDOZ INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz Inc | TOPOTECAN | topotecan hydrochloride | SOLUTION;INTRAVENOUS | 200199-003 | Feb 25, 2011 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Sandoz Inc | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075459-002 | Aug 22, 2000 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sandoz Inc | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201047-001 | Jun 6, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sandoz Inc | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075459-001 | Aug 22, 2000 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.